Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2011

Open Access 01-12-2011 | Methodology

Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus

Authors: Frank Nobels, Noëmi Debacker, Carlos Brotons, Moses Elisaf, Michel P Hermans, Georges Michel, Erik Muls, the OPTIMISE (OPtimal Type 2 dIabetes Management Including benchmarking and Standard trEatment) International Steering Committee

Published in: Cardiovascular Diabetology | Issue 1/2011

Login to get access

Abstract

Background

To investigate the effect of physician- and patient-specific feedback with benchmarking on the quality of care in adults with type 2 diabetes mellitus (T2DM).

Methods

Study centres in six European countries were randomised to either a benchmarking or control group. Physicians in both groups received feedback on modifiable outcome indicators (glycated haemoglobin [HbA1c], glycaemia, total cholesterol, high density lipoprotein-cholesterol, low density lipoprotein [LDL]-cholesterol and triglycerides) for each patient at 0, 4, 8 and 12 months, based on the four times yearly control visits recommended by international guidelines. The benchmarking group also received comparative results on three critical quality indicators of vascular risk (HbA1c, LDL-cholesterol and systolic blood pressure [SBP]), checked against the results of their colleagues from the same country, and versus pre-set targets. After 12 months of follow up, the percentage of patients achieving the pre-determined targets for the three critical quality indicators will be assessed in the two groups.

Results

Recruitment was completed in December 2008 with 3994 evaluable patients.

Conclusions

This paper discusses the study rationale and design of OPTIMISE, a randomised controlled study, that will help assess whether benchmarking is a useful clinical tool for improving outcomes in T2DM in primary care.

Trial registration

Appendix
Available only for authorised users
Literature
2.
go back to reference Jönsson B, CODE-2 Advisory Board: Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002, 45: S5-S12. 10.1007/s00125-002-0858-x.CrossRefPubMed Jönsson B, CODE-2 Advisory Board: Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002, 45: S5-S12. 10.1007/s00125-002-0858-x.CrossRefPubMed
3.
go back to reference UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998, 352: 837-853.CrossRef UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998, 352: 837-853.CrossRef
4.
go back to reference Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' Collaborators: Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet. 2005, 366: 1267-1278.CrossRefPubMed Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' Collaborators: Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet. 2005, 366: 1267-1278.CrossRefPubMed
5.
go back to reference Fuller J, Stevens LK, Chaturvedi N, Holloway JF: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev. 2000, 2: CD002188.PubMed Fuller J, Stevens LK, Chaturvedi N, Holloway JF: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev. 2000, 2: CD002188.PubMed
6.
go back to reference Institute of Medicine: Crossing the quality chasm: a new health system for the 21st century. 2001, Washington, DC: National Academy Press Institute of Medicine: Crossing the quality chasm: a new health system for the 21st century. 2001, Washington, DC: National Academy Press
7.
go back to reference Davidson M: How our current medical care system fails people with diabetes. Lack of timely, appropriate clinical decisions. Diabetes Care. 2009, 32: 370-372.PubMedCentralCrossRefPubMed Davidson M: How our current medical care system fails people with diabetes. Lack of timely, appropriate clinical decisions. Diabetes Care. 2009, 32: 370-372.PubMedCentralCrossRefPubMed
8.
go back to reference Weingarten S, Henning J, Badamgarav E, Knight K, Hasselblad V, Gano A, Ofman J: Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002, 325: 925-932. 10.1136/bmj.325.7370.925.PubMedCentralCrossRefPubMed Weingarten S, Henning J, Badamgarav E, Knight K, Hasselblad V, Gano A, Ofman J: Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002, 325: 925-932. 10.1136/bmj.325.7370.925.PubMedCentralCrossRefPubMed
9.
go back to reference Shojania K, Ranji S, McDonald K, Grimshaw J, Sundaram V, Rushakoff R, Owens D: Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control. A Meta-Regression Analysis. JAMA. 2006, 296: 427-440. 10.1001/jama.296.4.427.CrossRefPubMed Shojania K, Ranji S, McDonald K, Grimshaw J, Sundaram V, Rushakoff R, Owens D: Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control. A Meta-Regression Analysis. JAMA. 2006, 296: 427-440. 10.1001/jama.296.4.427.CrossRefPubMed
10.
go back to reference Maier M, Knopp A, Pusarnig S, Rurik I, Orozco D, Yaman H, van Eygen L, European Forum for Diabetes Care: Position Paper: Diabetes in Europe: role and contribution of Primary Care. Qual Prim Care. 2008, 16: 197-207.PubMed Maier M, Knopp A, Pusarnig S, Rurik I, Orozco D, Yaman H, van Eygen L, European Forum for Diabetes Care: Position Paper: Diabetes in Europe: role and contribution of Primary Care. Qual Prim Care. 2008, 16: 197-207.PubMed
11.
go back to reference Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA. 2002, 288: 2469-2475. 10.1001/jama.288.19.2469.CrossRefPubMed Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA. 2002, 288: 2469-2475. 10.1001/jama.288.19.2469.CrossRefPubMed
12.
go back to reference Bodenheimer T, Wagner E, Grumbach K: Improving primary care for patients with chronic illness. JAMA. 2002, 288: 1775-1779. 10.1001/jama.288.14.1775.CrossRefPubMed Bodenheimer T, Wagner E, Grumbach K: Improving primary care for patients with chronic illness. JAMA. 2002, 288: 1775-1779. 10.1001/jama.288.14.1775.CrossRefPubMed
13.
go back to reference Bodenheimer T, Wagner E, Grumbach K: Improving primary care for patients with chronic illness: the Chronic Care Model, Part 2. JAMA. 2002, 288: 1909-1914. 10.1001/jama.288.15.1909.CrossRefPubMed Bodenheimer T, Wagner E, Grumbach K: Improving primary care for patients with chronic illness: the Chronic Care Model, Part 2. JAMA. 2002, 288: 1909-1914. 10.1001/jama.288.15.1909.CrossRefPubMed
15.
go back to reference IDF Clinical Guidelines Task Force: Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation. 2005 IDF Clinical Guidelines Task Force: Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation. 2005
16.
go back to reference Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, American Heart Association; American Diabetes Association: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007, 30: 162-172. 10.2337/dc07-9917.CrossRefPubMed Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, American Heart Association; American Diabetes Association: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007, 30: 162-172. 10.2337/dc07-9917.CrossRefPubMed
17.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN): European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl 2): E1-E40.CrossRefPubMed Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN): European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl 2): E1-E40.CrossRefPubMed
18.
go back to reference American Diabetes Association: Clinical Practice Recommendations. Diabetes Care. 2007, 30 (Suppl 1): S1-S103. American Diabetes Association: Clinical Practice Recommendations. Diabetes Care. 2007, 30 (Suppl 1): S1-S103.
19.
go back to reference Eccles MP, Whitty PM, Speed C, Steen IN, Vanoli A, Hawthorne GC, Grimshaw JM, Wood LJ, McDowell D: A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial. Implement Sci. 2007, 2: 6-10.1186/1748-5908-2-6.PubMedCentralCrossRefPubMed Eccles MP, Whitty PM, Speed C, Steen IN, Vanoli A, Hawthorne GC, Grimshaw JM, Wood LJ, McDowell D: A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial. Implement Sci. 2007, 2: 6-10.1186/1748-5908-2-6.PubMedCentralCrossRefPubMed
20.
go back to reference Lachin JM: Biostatistical Methods. 2002, New York: John Wiley & Sons Lachin JM: Biostatistical Methods. 2002, New York: John Wiley & Sons
21.
go back to reference Machin D, Campbell M, Fayers P, Pinol A: Sample Size Tables for Clinical Studies. 1997, Oxford: Blackwell Science Machin D, Campbell M, Fayers P, Pinol A: Sample Size Tables for Clinical Studies. 1997, Oxford: Blackwell Science
22.
go back to reference Brohet C, De Backer G, Scheen AJ, Van Gaal LF, Duquenne V, Vissers E: Belgian evaluation of screening and treatment of hish-risk patients based on waist and age (Best study). Eur J Cardiac Prev Rehab. 2005, 12: 280.CrossRef Brohet C, De Backer G, Scheen AJ, Van Gaal LF, Duquenne V, Vissers E: Belgian evaluation of screening and treatment of hish-risk patients based on waist and age (Best study). Eur J Cardiac Prev Rehab. 2005, 12: 280.CrossRef
23.
go back to reference Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW: Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA. 2001, 285: 2871-2879. 10.1001/jama.285.22.2871.CrossRefPubMed Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW: Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA. 2001, 285: 2871-2879. 10.1001/jama.285.22.2871.CrossRefPubMed
24.
go back to reference Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348: 383-393. 10.1056/NEJMoa021778.CrossRefPubMed Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348: 383-393. 10.1056/NEJMoa021778.CrossRefPubMed
25.
go back to reference Merlani P, Garnerin P, Diby M, Ferring M, Ricou B: Quality improvement report: Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ. 2001, 323: 620-624. 10.1136/bmj.323.7313.620.PubMedCentralCrossRefPubMed Merlani P, Garnerin P, Diby M, Ferring M, Ricou B: Quality improvement report: Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ. 2001, 323: 620-624. 10.1136/bmj.323.7313.620.PubMedCentralCrossRefPubMed
26.
go back to reference Scholle SH, Roski J, Adams JL, Dunn DL, Kerr EA, Dugan DP, Jensen RE: Benchmarking physician performance: reliability of individual and composite measures. Am J Manag Care. 2008, 14: 833-838.PubMedCentralPubMed Scholle SH, Roski J, Adams JL, Dunn DL, Kerr EA, Dugan DP, Jensen RE: Benchmarking physician performance: reliability of individual and composite measures. Am J Manag Care. 2008, 14: 833-838.PubMedCentralPubMed
27.
go back to reference Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD: Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care. 2006, 15: 433-436. 10.1136/qshc.2006.018549.PubMedCentralCrossRefPubMed Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD: Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care. 2006, 15: 433-436. 10.1136/qshc.2006.018549.PubMedCentralCrossRefPubMed
28.
go back to reference de Grauw WJ, van Gerwen WH, van de Lisdonk EH, van den Hoogen HJ, van den Bosch WJ, van Weel C: Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. J Fam Pract. 2002, 51: 459-464.PubMed de Grauw WJ, van Gerwen WH, van de Lisdonk EH, van den Hoogen HJ, van den Bosch WJ, van Weel C: Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. J Fam Pract. 2002, 51: 459-464.PubMed
29.
go back to reference Valk GD, Renders CM, Kriegsman DM, Newton KM, Twisk JW, van Eijk JT, van der WG, Wagner EH: Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs. Health Serv Res. 2004, 39: 709-725. 10.1111/j.1475-6773.2004.00254.x.PubMedCentralCrossRefPubMed Valk GD, Renders CM, Kriegsman DM, Newton KM, Twisk JW, van Eijk JT, van der WG, Wagner EH: Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs. Health Serv Res. 2004, 39: 709-725. 10.1111/j.1475-6773.2004.00254.x.PubMedCentralCrossRefPubMed
30.
go back to reference Hunt JS, Siemienczuk J, Gillanders W, Leblanc BH, Rozenfeld Y, Bonin K, Pape G: The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study. Inform Prim Care. 2009, 17: 165-174.PubMed Hunt JS, Siemienczuk J, Gillanders W, Leblanc BH, Rozenfeld Y, Bonin K, Pape G: The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study. Inform Prim Care. 2009, 17: 165-174.PubMed
31.
go back to reference Club Diabete Sicili@: Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics. Diabetes Care. 2008, 31: 57-62. 10.2337/dc08-0284.CrossRef Club Diabete Sicili@: Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics. Diabetes Care. 2008, 31: 57-62. 10.2337/dc08-0284.CrossRef
32.
go back to reference Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N: Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ. 2009, 338: b1870-10.1136/bmj.b1870.PubMedCentralCrossRefPubMed Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N: Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ. 2009, 338: b1870-10.1136/bmj.b1870.PubMedCentralCrossRefPubMed
33.
go back to reference Kristensen JK, Lauritzen T: Quality indicators of type 2-diabetes monitoring during 2000-2005. Ugeskr Laeger. 2009, 171: 130-134.PubMed Kristensen JK, Lauritzen T: Quality indicators of type 2-diabetes monitoring during 2000-2005. Ugeskr Laeger. 2009, 171: 130-134.PubMed
34.
go back to reference Guldberg T, Lauritzen T, Kristensen J, Vedsted P: The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Family Practice. 2009, 10: 30-10.1186/1471-2296-10-30.PubMedCentralCrossRefPubMed Guldberg T, Lauritzen T, Kristensen J, Vedsted P: The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Family Practice. 2009, 10: 30-10.1186/1471-2296-10-30.PubMedCentralCrossRefPubMed
35.
go back to reference Smith SA, Shah ND, Bryant SC, Christianson TJ, Bjornsen SS, Giesler PD, Krause K, Erwin PJ, Montori VM, Evidens Research Group: Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. Mayo Clin Proc. 2008, 83: 747-757. 10.4065/83.7.747.CrossRefPubMed Smith SA, Shah ND, Bryant SC, Christianson TJ, Bjornsen SS, Giesler PD, Krause K, Erwin PJ, Montori VM, Evidens Research Group: Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. Mayo Clin Proc. 2008, 83: 747-757. 10.4065/83.7.747.CrossRefPubMed
36.
go back to reference O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL: Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care. 2009, 32: 1158-1163. 10.2337/dc08-2247.PubMedCentralCrossRefPubMed O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL: Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care. 2009, 32: 1158-1163. 10.2337/dc08-2247.PubMedCentralCrossRefPubMed
37.
go back to reference Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ: Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001, 24: 1821-1833. 10.2337/diacare.24.10.1821.CrossRefPubMed Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ: Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001, 24: 1821-1833. 10.2337/diacare.24.10.1821.CrossRefPubMed
38.
39.
go back to reference Debacker N, Nobels F, Vandenberghe H, Van Crombrugge P, Scheen A, Van Casteren V: Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience. Diabet Med. 2008, 25: 179-185. 10.1111/j.1464-5491.2007.02378.x.CrossRefPubMed Debacker N, Nobels F, Vandenberghe H, Van Crombrugge P, Scheen A, Van Casteren V: Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience. Diabet Med. 2008, 25: 179-185. 10.1111/j.1464-5491.2007.02378.x.CrossRefPubMed
40.
go back to reference Debacker N, Van Crombrugge P, Sourdeau L, Libeer J, Van Casteren V, Scheen A, Nobels F: A nationwide external quality assessment programme for HbA1c in Belgium: an example of a quality cycle [abstract]. Diabetic Medicine. 2006, 23 (Suppl 4): 5-199. Debacker N, Van Crombrugge P, Sourdeau L, Libeer J, Van Casteren V, Scheen A, Nobels F: A nationwide external quality assessment programme for HbA1c in Belgium: an example of a quality cycle [abstract]. Diabetic Medicine. 2006, 23 (Suppl 4): 5-199.
Metadata
Title
Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus
Authors
Frank Nobels
Noëmi Debacker
Carlos Brotons
Moses Elisaf
Michel P Hermans
Georges Michel
Erik Muls
the OPTIMISE (OPtimal Type 2 dIabetes Management Including benchmarking and Standard trEatment) International Steering Committee
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-10-82

Other articles of this Issue 1/2011

Cardiovascular Diabetology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.